
The prosthetics manufacturer went public this morning with a festive IPO ceremony. The initial price was €72 after issuance at €66 and subscription between €62 and €66.
October 9, 2025. FRANKFURT (Frankfurt Stock Exchange). As of today, Ottobock SE & Co. KGaA (DE000BCK2223) is listed in the Prime Standard segment of the Frankfurt Stock Exchange.
BNP Paribas, Deutsche Bank, and Goldman Sachs Bank Europe acted as joint global coordinators and joint bookrunners for the IPO. Bank of America Securities and UBS Investment Bank acted as senior joint bookrunners, with Jefferies and UniCredit also acting as joint bookrunners. Commerzbank was senior co-lead manager, while DZ Bank and LBBW were co-lead managers. Lilja & Co. acted as financial advisor to Näder Holding and Ottobock. Baader Bank is the designated sponsor in Xetra trading and specialist at the Frankfurt Stock Exchange.
According to its own information, Ottobock is a medical technology company that operates worldwide in the field of bionics. Its main areas of business include prosthetics, orthotics, and exoskeletons. Founded in 1919, the company generated sales of €1.43 billion and adjusted operating profit (EBITDA) of €321 million last year with almost 9,300 employees worldwide.
Photos: martinjoppen.de.
9 October, 2025 © Deutsche Börse AG
